May 13
|
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
|
May 6
|
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
|
May 4
|
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported And Analysts Have Been Lifting Their Price Targets
|
May 3
|
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript
|
May 3
|
PROCEPT BioRobotics First Quarter 2024 Earnings: Beats Expectations
|
May 1
|
Biotech Leader Procept BioRobotics Surges Past Buy Point On Earnings
|
May 1
|
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
|
May 1
|
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
|
Apr 29
|
Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
|
Apr 23
|
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
|
Apr 4
|
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
|
Apr 2
|
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
|
Mar 26
|
Masimo (MASI) Soars 3.3%: Is Further Upside Left in the Stock?
|
Mar 20
|
PROCEPT BioRobotics Corp (PRCT) President and CEO Reza Zadno Sells Company Shares
|
Mar 8
|
EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics Corp (PRCT)
|
Mar 7
|
Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT)
|
Jan 12
|
EVP, CLO, CORP. SEC. Alaleh Nouri Sells 16,000 Shares of PROCEPT BioRobotics Corp
|
Jan 10
|
Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength?
|
Jan 8
|
PROCEPT BioRoboticsĀ® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
|
Dec 10
|
Insider Sell Alert: Director Frederic Moll Sells 79,000 Shares of PROCEPT BioRobotics Corp (PRCT)
|